Research / KRO / Fundamental state Inspectable configuration
State dimensions Filing 0001104659-26-025219 General Corporate
Debt relative to revenue 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.debt_to_revenue
29.98% · OPTIONAL · VALID
Capex intensity 41th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.31% · OPTIONAL · VALID
Operating cash generation 29th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.13% · OPTIONAL · VALID
Revenue growth 46th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
-1.47% · CORE · VALID
Inventory pressure 12th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
33.81% · OPTIONAL · VALID
Gross margin 29th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
11.46% · CORE · VALID
Operating margin 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
-1.96% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.86% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/6 normalized Level 3 Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/6 normalized Level 3 Jun 30, 2022 0/6 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/7 normalized Level 3 Sep 30, 2023 6/7 normalized Level 3 Dec 31, 2023 6/8 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 6/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 137.05%
Current 29.98%
Delta -107.08% Capex Intensity Increased
Previous 2.08%
Current 2.31%
Delta 0.23% Cash Generation Increased
Previous -1.73%
Current 0.13%
Delta 1.86% Growth Increased
Previous -5.74%
Current -1.47%
Delta 4.27% Inventory Pressure Decreased
Previous 144.25%
Current 33.81%
Delta -110.45% Margin Increased
Previous 10.29%
Current 11.46%
Delta 1.17% Profitability Increased
Previous -4.20%
Current -1.96%
Delta 2.24% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.